Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Rare Disease Genetic Testing Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE

Global Rare Disease Genetic Testing Market

Published Date : Apr-2020
Report ID : ER- 28661
Format : PDF | XLS | PPT
Pages : 171+
Author : Julie
Reviewed By : Coralia Joe
Publisher : Extent Research
Category : Service & Software

Extent Research has added a new report titled “Global Rare Disease Genetic Testing Market: By Type (Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, Fluorescence in Situ Hybridization (FISH), Sanger Sequencing, Karyotyping, Others, ), By Application (Research Laboratories and CROs, Diagnostic Laboratories, Hospitals and Clinics, Others, ), Regional Analysis and Forecast 2035.” The report promises to offer all the key insights about the Rare Disease Genetic Testing market thus helping our clients to have a clear view about the current market scenario.

Data provided by Extent Research. Source: https://www.extentresearch.com/rare-disease-genetic-testing-market

The overall market size in terms of value and volume has been calculated by the research analysts along with the expected growth rate for the forecast period. The anticipated market value for the Rare Disease Genetic Testing market is in terms of USD Million/Billion. It is expected that the Rare Disease Genetic Testing market will witness a steady and a good growth rate during 2026 to 2035.

In the research study the research analysts have conducted a detailed study about all the market segments and were able to categorize the segments and the regions that should be concentrated by the market players in the coming years. The regional dominance and the highest growing regions are properly segregated for the clients so that they can channelize their investments and strategize their plans accordingly. The major segments that are categorized for the Rare Disease Genetic Testing market includes by Application Research Laboratories and CROs, Diagnostic Laboratories, Hospitals and Clinics, Others, , by Product type Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, Fluorescence in Situ Hybridization (FISH), Sanger Sequencing, Karyotyping, Others, .

The market dynamics are well explained in the Rare Disease Genetic Testing report. The attributes that are incorporated in the report includes the market drivers, opportunities, the technologies that are helping the market to prosper, and much more. The limitations that are expected to hamper the growth of the Rare Disease Genetic Testing market are also included with proper solutions by the market experts and the research analysts that will help overcome the same.

Some of the major market players that are enlisted in the report include Quest Diagnostics, Centogene, Invitae Corporation, 3billion, Arup Laboratories, Eurofins Scientific, Strand Life Sciences, Ambry Genetics, Perkin Elmer, Macrogen, Baylor Genetics, Color Genomics, Preventiongenetics, Progenity, Coopersurgical, Fulgent Genetics, Myriad Genetics, LabCorp, Opko Health, . The competitive landscape shared by the competitive players in the Rare Disease Genetic Testing market are well analyzed by the research analysts.

Report Objectives:

  • To define and describe the complete overview of the Rare Disease Genetic Testing Market.
  • To offer complete information about the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To estimate the market size for Global Rare Disease Genetic Testing Market in terms of value and volume.
  • To study the individual growth trends of the providers of Global Rare Disease Genetic Testing Market, their future expansions, and analyze their contributions to the market
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contribution to the total market, covered by Global Rare Disease Genetic Testing Market and various regions.

Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
1.2.2 Next-Generation Sequencing (NGS)
1.2.3 Array Technology
1.2.4 PCR-based Testing
1.2.5 Fluorescence in Situ Hybridization (FISH)
1.2.6 Sanger Sequencing
1.2.7 Karyotyping
1.2.8 Others
1.3 Market by Application
1.3.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
1.3.2 Research Laboratories and CROs
1.3.3 Diagnostic Laboratories
1.3.4 Hospitals and Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rare Disease Genetic Testing Market Perspective (2017-2035)
2.2 Rare Disease Genetic Testing Growth Trends by Region
2.2.1 Rare Disease Genetic Testing Market Size by Region: 2017 VS 2021 VS 2035
2.2.2 Rare Disease Genetic Testing Historic Market Size by Region (2017-2022)
2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Region (2023-2035)
2.3 Rare Disease Genetic Testing Market Dynamics
2.3.1 Rare Disease Genetic Testing Industry Trends
2.3.2 Rare Disease Genetic Testing Market Drivers
2.3.3 Rare Disease Genetic Testing Market Challenges
2.3.4 Rare Disease Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Disease Genetic Testing Players by Revenue
3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2017-2022)
3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2021
3.5 Rare Disease Genetic Testing Key Players Head office and Area Served
3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
3.7 Date of Enter into Rare Disease Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Disease Genetic Testing Breakdown Data by Type
4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2017-2022)
4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2023-2035)
5 Rare Disease Genetic Testing Breakdown Data by Application
5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2017-2022)
5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2023-2035)
6 North America
6.1 North America Rare Disease Genetic Testing Market Size (2017-2035)
6.2 North America Rare Disease Genetic Testing Market Size by Type
6.2.1 North America Rare Disease Genetic Testing Market Size by Type (2017-2022)
6.2.2 North America Rare Disease Genetic Testing Market Size by Type (2023-2035)
6.2.3 North America Rare Disease Genetic Testing Market Share by Type (2017-2035)
6.3 North America Rare Disease Genetic Testing Market Size by Application
6.3.1 North America Rare Disease Genetic Testing Market Size by Application (2017-2022)
6.3.2 North America Rare Disease Genetic Testing Market Size by Application (2023-2035)
6.3.3 North America Rare Disease Genetic Testing Market Share by Application (2017-2035)
6.4 North America Rare Disease Genetic Testing Market Size by Country
6.4.1 North America Rare Disease Genetic Testing Market Size by Country (2017-2022)
6.4.2 North America Rare Disease Genetic Testing Market Size by Country (2023-2035)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Rare Disease Genetic Testing Market Size (2017-2035)
7.2 Europe Rare Disease Genetic Testing Market Size by Type
7.2.1 Europe Rare Disease Genetic Testing Market Size by Type (2017-2022)
7.2.2 Europe Rare Disease Genetic Testing Market Size by Type (2023-2035)
7.2.3 Europe Rare Disease Genetic Testing Market Share by Type (2017-2035)
7.3 Europe Rare Disease Genetic Testing Market Size by Application
7.3.1 Europe Rare Disease Genetic Testing Market Size by Application (2017-2022)
7.3.2 Europe Rare Disease Genetic Testing Market Size by Application (2023-2035)
7.3.3 Europe Rare Disease Genetic Testing Market Share by Application (2017-2035)
7.4 Europe Rare Disease Genetic Testing Market Size by Country
7.4.1 Europe Rare Disease Genetic Testing Market Size by Country (2017-2022)
7.4.2 Europe Rare Disease Genetic Testing Market Size by Country (2023-2035)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Disease Genetic Testing Market Size (2017-2035)
8.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type
8.2.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2023-2035)
8.2.3 Asia-Pacific Rare Disease Genetic Testing Market Share by Type (2017-2035)
8.3 Asia-Pacific Rare Disease Genetic Testing Market Size by Application
8.3.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2023-2035)
8.3.3 Asia-Pacific Rare Disease Genetic Testing Market Share by Application (2017-2035)
8.4 Asia-Pacific Rare Disease Genetic Testing Market Size by Region
8.4.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2023-2035)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rare Disease Genetic Testing Market Size (2017-2035)
9.2 Latin America Rare Disease Genetic Testing Market Size by Type
9.2.1 Latin America Rare Disease Genetic Testing Market Size by Type (2017-2022)
9.2.2 Latin America Rare Disease Genetic Testing Market Size by Type (2023-2035)
9.2.3 Latin America Rare Disease Genetic Testing Market Share by Type (2017-2035)
9.3 Latin America Rare Disease Genetic Testing Market Size by Application
9.3.1 Latin America Rare Disease Genetic Testing Market Size by Application (2017-2022)
9.3.2 Latin America Rare Disease Genetic Testing Market Size by Application (2023-2035)
9.3.3 Latin America Rare Disease Genetic Testing Market Share by Application (2017-2035)
9.4 Latin America Rare Disease Genetic Testing Market Size by Country
9.4.1 Latin America Rare Disease Genetic Testing Market Size by Country (2017-2022)
9.4.2 Latin America Rare Disease Genetic Testing Market Size by Country (2023-2035)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Disease Genetic Testing Market Size (2017-2035)
10.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type
10.2.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2023-2035)
10.2.3 Middle East & Africa Rare Disease Genetic Testing Market Share by Type (2017-2035)
10.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application
10.3.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2023-2035)
10.3.3 Middle East & Africa Rare Disease Genetic Testing Market Share by Application (2017-2035)
10.4 Middle East & Africa Rare Disease Genetic Testing Market Size by Country
10.4.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2023-2035)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.1.5 Quest Diagnostics Recent Developments
11.2 Centogene
11.2.1 Centogene Company Details
11.2.2 Centogene Business Overview
11.2.3 Centogene Rare Disease Genetic Testing Introduction
11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.2.5 Centogene Recent Developments
11.3 Invitae Corporation
11.3.1 Invitae Corporation Company Details
11.3.2 Invitae Corporation Business Overview
11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.3.5 Invitae Corporation Recent Developments
11.4 3billion
11.4.1 3billion Company Details
11.4.2 3billion Business Overview
11.4.3 3billion Rare Disease Genetic Testing Introduction
11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.4.5 3billion Recent Developments
11.5 Arup Laboratories
11.5.1 Arup Laboratories Company Details
11.5.2 Arup Laboratories Business Overview
11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.5.5 Arup Laboratories Recent Developments
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Details
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.6.5 Eurofins Scientific Recent Developments
11.7 Strand Life Sciences
11.7.1 Strand Life Sciences Company Details
11.7.2 Strand Life Sciences Business Overview
11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.7.5 Strand Life Sciences Recent Developments
11.8 Ambry Genetics
11.8.1 Ambry Genetics Company Details
11.8.2 Ambry Genetics Business Overview
11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.8.5 Ambry Genetics Recent Developments
11.9 Perkin Elmer
11.9.1 Perkin Elmer Company Details
11.9.2 Perkin Elmer Business Overview
11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.9.5 Perkin Elmer Recent Developments
11.10 Macrogen
11.10.1 Macrogen Company Details
11.10.2 Macrogen Business Overview
11.10.3 Macrogen Rare Disease Genetic Testing Introduction
11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.10.5 Macrogen Recent Developments
11.11 Baylor Genetics
11.11.1 Baylor Genetics Company Details
11.11.2 Baylor Genetics Business Overview
11.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
11.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.11.5 Baylor Genetics Recent Developments
11.12 Color Genomics
11.12.1 Color Genomics Company Details
11.12.2 Color Genomics Business Overview
11.12.3 Color Genomics Rare Disease Genetic Testing Introduction
11.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.12.5 Color Genomics Recent Developments
11.13 Preventiongenetics
11.13.1 Preventiongenetics Company Details
11.13.2 Preventiongenetics Business Overview
11.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
11.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.13.5 Preventiongenetics Recent Developments
11.14 Progenity
11.14.1 Progenity Company Details
11.14.2 Progenity Business Overview
11.14.3 Progenity Rare Disease Genetic Testing Introduction
11.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.14.5 Progenity Recent Developments
11.15 Coopersurgical
11.15.1 Coopersurgical Company Details
11.15.2 Coopersurgical Business Overview
11.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
11.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.15.5 Coopersurgical Recent Developments
11.16 Fulgent Genetics
11.16.1 Fulgent Genetics Company Details
11.16.2 Fulgent Genetics Business Overview
11.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
11.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.16.5 Fulgent Genetics Recent Developments
11.17 Myriad Genetics
11.17.1 Myriad Genetics Company Details
11.17.2 Myriad Genetics Business Overview
11.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
11.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.17.5 Myriad Genetics Recent Developments
11.18 LabCorp
11.18.1 LabCorp Company Details
11.18.2 LabCorp Business Overview
11.18.3 LabCorp Rare Disease Genetic Testing Introduction
11.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.18.5 LabCorp Recent Developments
11.19 Opko Health
11.19.1 Opko Health Company Details
11.19.2 Opko Health Business Overview
11.19.3 Opko Health Rare Disease Genetic Testing Introduction
11.19.4 Opko Health Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.19.5 Opko Health Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

Data provided by Extent Research. Source: https://www.extentresearch.com/rare-disease-genetic-testing-market